INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2020

Omega-3 fatty acids produce variable cardiovascular effects depending on their specific formulation and dosage.

This review summarizes findings from contemporary clinical trials investigating the cardioprotective effects of omega-3 fatty acids, specifically EPA and DHA. While early trials showed cardiovascular benefits with fish oils, subsequent studies largely failed to replicate these results. Recent trials have shown cardiovascular risk reduction with high-dose EPA, but not with lower doses or a carboxylic acid formulation combining EPA and DHA.

Study type
Narrative review of clinical trials
Who was studied
Participants in contemporary clinical trials of omega-3 fatty acids
What was measured
Cardiovascular outcomes and risk reduction

THE PAPER

The fish-oil paradox.

Nicholls SJ, Nelson AJ. Curr Opin Lipidol, 2020.

PubMed 33027227 ↗DOI 10.1093/eurheartj/ehaa652 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.